News Releases
Jun 22 2022
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2022 After Market Close on June 29, 2022
Jun 14 2022
Avid Bioservices Announces Launch of Analytical and Process Development Suites Within New, World-Class Viral Vector Development and Manufacturing Facility
Jun 13 2022
Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business
Mar 16 2022
Avid Bioservices to Participate in KeyBanc Capital Markets Life Sciences & MedTech Forum
Mar 8 2022
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2022 and Recent Developments
Mar 1 2022
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2022 after Market Close on March 8, 2022
Jan 10 2022
Avid Bioservices Announces Official Opening of Second Downstream Processing Suite Within Myford North Facility
Dec 7 2021
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2021 and Recent Developments
Nov 30 2021
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2022 After Market Close on December 7, 2021
Nov 4 2021
Avid Bioservices Appoints Elie G. Hanania, Ph.D., as Vice President, Process Development, Viral Vector Technologies